Matches in Nanopublications for { ?s ?p "[Bisulfite genomic sequencing revealed methylation of the NAT1 gene in 25 of the control cancers (33.8%) and 23 of the resistant tumors (62.2%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP245375.RAFvk5d0J6pkdA2Ar2Szm4s3qyJrATa_Gak0_BhitzYwY130_assertion description "[Bisulfite genomic sequencing revealed methylation of the NAT1 gene in 25 of the control cancers (33.8%) and 23 of the resistant tumors (62.2%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP245375.RAFvk5d0J6pkdA2Ar2Szm4s3qyJrATa_Gak0_BhitzYwY130_provenance.
- NP275244.RAFLq-a2SSuVotbvWPha_P8DHcdT-BEQSgDr9Earv48kg130_assertion description "[Bisulfite genomic sequencing revealed methylation of the NAT1 gene in 25 of the control cancers (33.8%) and 23 of the resistant tumors (62.2%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP275244.RAFLq-a2SSuVotbvWPha_P8DHcdT-BEQSgDr9Earv48kg130_provenance.
- NP472279.RAT3ehyUxEbbobKlVRjM7FmzFK6wmTJpklPa64QedUAS8130_assertion description "[Bisulfite genomic sequencing revealed methylation of the NAT1 gene in 25 of the control cancers (33.8%) and 23 of the resistant tumors (62.2%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP472279.RAT3ehyUxEbbobKlVRjM7FmzFK6wmTJpklPa64QedUAS8130_provenance.
- NP372468.RATfVFH77JoGTIE-QwxqZ1KgJxTz8ENsujbl5K_dqzftQ130_assertion description "[Bisulfite genomic sequencing revealed methylation of the NAT1 gene in 25 of the control cancers (33.8%) and 23 of the resistant tumors (62.2%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP372468.RATfVFH77JoGTIE-QwxqZ1KgJxTz8ENsujbl5K_dqzftQ130_provenance.
- NP857773.RAa7mY-C6EbNxZtuAgs_MyUokCrM4SAb2kRilPwW3XtLM130_assertion description "[Bisulfite genomic sequencing revealed methylation of the NAT1 gene in 25 of the control cancers (33.8%) and 23 of the resistant tumors (62.2%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP857773.RAa7mY-C6EbNxZtuAgs_MyUokCrM4SAb2kRilPwW3XtLM130_provenance.
- NP217309.RAp2oI0WCUXMFKx32pLQm1h_Kfj9YMXpM-oRq3SJSDgoo130_assertion description "[Bisulfite genomic sequencing revealed methylation of the NAT1 gene in 25 of the control cancers (33.8%) and 23 of the resistant tumors (62.2%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP217309.RAp2oI0WCUXMFKx32pLQm1h_Kfj9YMXpM-oRq3SJSDgoo130_provenance.
- NP697923.RA_-15lVxIobZTIRR_Jxt4WvZjxSV_i457qpDlfgDqvzg130_assertion description "[Bisulfite genomic sequencing revealed methylation of the NAT1 gene in 25 of the control cancers (33.8%) and 23 of the resistant tumors (62.2%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP697923.RA_-15lVxIobZTIRR_Jxt4WvZjxSV_i457qpDlfgDqvzg130_provenance.
- NP974325.RAzj9-_gmPs49lAc7YmNgNgicbiySSxXbkelKmgRRSVmE130_assertion description "[Bisulfite genomic sequencing revealed methylation of the NAT1 gene in 25 of the control cancers (33.8%) and 23 of the resistant tumors (62.2%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP974325.RAzj9-_gmPs49lAc7YmNgNgicbiySSxXbkelKmgRRSVmE130_provenance.